Recent News

• 08.06.2026 - BioLife Solutions Reports Second Quarter 2026 Financial Results
• 07.22.2026 - Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
• 07.22.2026 - Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
• 06.30.2026 - BioLife and Qkine Partner to Streamline Cell and Gene Therapy Workflows
• 05.26.2026 - The Cell Summit ’26
• 05.07.2026 - BioLife Solutions Reports First Quarter 2026 Financial Results
• 04.23.2026 - BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
• 04.21.2026 - BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCase
• 04.10.2026 - Sanguine Bio Standardizes on CryoStor® to Support Consistent PBMC Cryopreservation
• 02.26.2026 - BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations

Recent Filings

• 08.06.2026 - EX-99.1 EX-99.1
• 08.06.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.06.2026 - 8-K Current report
• 08.04.2026 - 425 Prospectuses and communications, business combinations
• 08.03.2026 - 8-K Current report
• 08.03.2026 - EX-99.1 EX-99.1
• 07.24.2026 - 425 Prospectuses and communications, business combinations
• 07.22.2026 - 8-K Current report
• 07.22.2026 - 425 Prospectuses and communications, business combinations
• 07.22.2026 - EX-99.1 EX-99.1